Burzynski Research Institute Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$5.92 M |
Shares Outstanding |
131.45 M |
Public Float |
24.97 M |
Address |
9432 Katy Freeway Houston Texas 77055 United States |
Employees | - |
Website | http://www.burzynskiresearch.com |
Updated | 07/08/2019 |
Burzynski Research Institute, Inc. engages in the research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer. The company was founded by Stanislaw R. Burzynski in 1984 and is headquartered in Houston, TX. |